InsiderClue
Stocks · Health care · Pharmaceutical Preparations

Edgewise Therapeutics, Inc.

EWTX Clue Score35
United States Fiscal year ends December CIK 0001710072 Results filed 4 Nov 2026
Add to watchlist

What the insiders did Mostly scheduled

Individual transactions

29
Insider
Date
Role
Action
Shares
Price
Amount
Kevin Koch
12 Aug 2026
President and CEO
Sold after exercise
913
$44.33
$40.47K
Kevin Koch
12 Aug 2026
President and CEO
Sold after exercise
8,276
$43.66
$361.32K
Kevin Koch
12 Aug 2026
President and CEO
Sold after exercise
8,782
$43.64
$383.25K
Behrad Derakhshan
12 Aug 2026
Chief Business Officer
Sold after exercise
2,475
$43.70
$108.15K
Behrad Derakhshan
12 Aug 2026
Chief Business Officer
Sold after exercise
150
$44.44
$6.67K
Behrad Derakhshan
12 Aug 2026
Chief Business Officer
Sold after exercise
304
$44.50
$13.53K
Behrad Derakhshan
12 Aug 2026
Chief Business Officer
Sold after exercise
2,171
$43.79
$95.08K
John R Moore
12 Aug 2026
General Counsel
Sold after exercise
2,419
$43.80
$105.95K
John R Moore
12 Aug 2026
General Counsel
Sold after exercise
99
$44.50
$4.41K
John R Moore
12 Aug 2026
General Counsel
Sold after exercise
59
$44.41
$2.62K
John R Moore
12 Aug 2026
General Counsel
Sold after exercise
2,439
$43.81
$106.85K
Alan J Russell
12 Aug 2026
Chief Scientific Officer
Sold after exercise
390
$44.46
$17.34K
Alan J Russell
12 Aug 2026
Chief Scientific Officer
Sold after exercise
2,273
$43.68
$99.28K
Alan J Russell
12 Aug 2026
Chief Scientific Officer
Sold after exercise
3,238
$43.68
$141.43K
Joanne M. Donovan
12 Aug 2026
CMO
Sold after exercise
800
$44.52
$35.61K
Joanne M. Donovan
12 Aug 2026
CMO
Sold after exercise
104
$44.43
$4.62K
Joanne M. Donovan
12 Aug 2026
CMO
Sold after exercise
2,779
$43.71
$121.46K
Joanne M. Donovan
12 Aug 2026
CMO
Sold after exercise
2,839
$43.78
$124.30K
Alan J Russell
1 Jul 2026
Chief Scientific Officer
Sold after exercise
69,648
$39.41
$2.74M
Alan J Russell
1 Jul 2026
Chief Scientific Officer
Sold after exercise
130,352
$39.41
$5.14M
Joanne M. Donovan
5 May 2026
CMO
Sold after exercise
50,000
$38.57
$1.93M
Joanne M. Donovan
1 Apr 2026
CMO
Sold after exercise
28,662
$32.31
$926.10K
Joanne M. Donovan
31 Mar 2026
CMO
Sold after exercise
21,338
$32.12
$685.31K
Badreddin Edris
21 Jan 2026
Director
Sold after exercise
66,477
$29.44
$1.96M
Badreddin Edris
21 Jan 2026
Director
Sold after exercise
10,463
$29.44
$308.03K
Badreddin Edris
21 Jan 2026
Director
Sold after exercise
7,605
$29.44
$223.89K
Badreddin Edris
21 Jan 2026
Director
Sold after exercise
17,236
$29.44
$507.43K
Badreddin Edris
21 Jan 2026
Director
Sold after exercise
13,690
$29.44
$403.03K
Alan J Russell
12 Nov 2025
Chief Scientific Officer
Sold after exercise
100,000
$21.12
$2.11M
Show all 34 transactions →

What was left out

Form 4 filings counted 27
Amendments (4/A) skipped 5
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 2
Sales straight out of an exercise 29
Sales at will 2
Transactions with no price 0
Shares from compensation/vesting 608,158
History held since 30 Mar 2021